NEW!
June 17, 2019

Business

Presentation of New Preclinical Data of SCO-267, a GPR40 agonist, at The American Diabetes Association’s 79th Scientific Sessions167 KB

June 11, 2019

Business

Publication regarding a preclinical study of SCO-267,a novel GPR40 agonist488 KB

June 03, 2019

Business

Publication regarding preclinical studies of SCO-792, a novel enteropeptidase inhibitor606 KB